Hormonal Contraceptives Market Growth Outlook Reveals A CAGR Of 2.1% And A Market Value Of $15.82 Billion By 2030
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Hormonal Contraceptives Market Expansion From $14.57 Billion In 2026 To $15.82 Billion In 2030
The market for hormonal contraceptives experienced slight expansion in recent times, with its valuation increasing from $14.4 billion in 2025 to $14.58 billion in 2026, reflecting a compound annual growth rate (CAGR) of 1.2%. This historical growth was fueled by greater awareness regarding family planning, the launch of combined oral contraceptives, government-led reproductive health programs, higher levels of urbanization, and a rising number of gynecology clinics.
The size of the hormonal contraceptives market is anticipated to experience consistent expansion over the coming years, ultimately reaching $15.82 billion by 2030, reflecting a compound annual growth rate (CAGR) of 2.1%. This projected growth during the forecast period is driven by factors such as progress in tailoring hormone therapies to individuals, the emergence of contraceptive products for men, the growing reach of online sales channels for contraceptives, the incorporation of digital health tools, and a heightened emphasis on preventing sexually transmitted diseases. Key developments expected in this timeframe encompass the growing adoption of personalized, hormone-based birth control methods, heightened awareness among consumers regarding both reversible and permanent options, the expansion of telehealth services and online contraceptive access, the rollout of new male birth control alternatives, and a stronger emphasis on contraceptives that offer dual protection against STDs.
Download A Free Sample Report For Comprehensive Market Insights:
Hormonal Contraceptives Market Growth Momentum: Which Factors Are Influencing Demand?
Growing knowledge about hormonal contraceptives has fostered a more informed and empowered population, enabling individuals to select options that fit their reproductive aspirations and way of life. With greater understanding of contraceptive choices, people are more capable of making improved decisions regarding their reproductive health, which subsequently boosts the uptake of hormonal contraceptives that suit their family planning needs and lifestyle preferences. For example, in July 2025, the World Health Organization (WHO), a Switzerland-based UN agency specializing in international public health, reported that 874 million women are currently using modern contraceptives, and access to family planning bolsters public health, advances gender equality, strengthens health systems, and fosters economic development. A further 70 million women are expected to gain access by 2030. Heightened awareness of contraceptive benefits and usage significantly drives the hormonal contraceptives market forward.
Healthcare spending is on the rise, and this is anticipated to fuel expansion in the hormonal contraceptives market going forward. Healthcare expenditure encompasses the total financial resources allocated by individuals, organizations, or governments to prevent, treat, and manage health conditions. It is growing due to progress in medical technology, as new diagnostic instruments, treatments, and innovative therapies often come with higher costs, leading to increased overall spending in the sector. This increase promotes the use of hormonal contraceptives by enhancing access, affordability, awareness, and by supporting research and development along with family planning initiatives. As an illustration, in December 2024, the Centers for Medicare & Medicaid Services, a US agency that oversees Medicare and Medicaid programs, noted that in 2023, U.S. healthcare spending rose by 7.5%, reaching $4.9 trillion, roughly $14,570 per person. Consequently, the rising healthcare expenditure is propelling growth in the hormonal contraceptives market.
Hormonal Contraceptives Market Segmentation Trends And Revenue Drivers
The hormonal contraceptives market covered in this report is segmented –
1) By Product: Pills, Injectable Birth Control, Vaginal Rings, Others
2) By End User: Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers
3) By Hormones: Progestin-Only, Combined Hormones
4) By Distribution Channel: Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels
Subsegments:
1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills
2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants
3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings
4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men
Hormonal Contraceptives Market Trends Reshaping Industry Growth
Key players in the hormonal contraceptives sector are developing groundbreaking items, including over-the-counter daily oral birth control pills, aimed at improving user access and simplicity. An over-the-counter daily oral contraceptive refers to a birth control pill accessible for purchase without requiring a prescription from a medical professional. As an example, in July 2023, Perrigo Company PLC, a U.S.-based producer of private-label nonprescription pharmaceuticals, secured clearance from the Food and Drug Administration (FDA), a U.S. federal agency dedicated to safeguarding public health, for its product Opill. Opill represents the first daily oral contraceptive available without a prescription, becoming obtainable for consumers without needing a doctor’s order. The launch of Opill signifies a critical milestone in reproductive healthcare, enabling individuals to obtain reliable contraception free from the obstacles associated with securing a prescription or scheduling a medical visit.
Hormonal Contraceptives Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the hormonal contraceptives market are Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy Care, Mylan Laboratories
Access The Complete Hormonal Contraceptives Market Report:
Hormonal Contraceptives Market Regional Analysis And Leading Geography
North America was the largest region in the hormonal contraceptives market share in 2025. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
